Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06289985 · ClinicalTrials.gov registry record · NA
StrokeNet Thrombectomy Endovascular Platform
A NA study of Ischemic Stroke, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 1,600
- Enrollment target
- 20
- Study locations
NCT06289985: Recruiting NA study of Ischemic Stroke, sponsored by Medical University of South Carolina.
NCT06289985 is a NA study of Ischemic Stroke that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 1,600 participants, above the 1,439-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (11% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06289985, a NA study of Ischemic Stroke, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,600 participants
- Enrollment target
- 20
- Study locations
Study Summary
STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).
Primary Outcome
The modified Rankin Score is a 7-outcome ordinal scale where 0 = No symptoms and 6= Dead. The analysis of the primary endpoint will be based on a utility weighting of the 7 outcomes, where 0 represents the worst possible health state and 1 represents the best possible state.
Conditions Studied
Interventions
- DEVICE Endovascular thrombectomy with any FDA-approved category POL or NRY device
- OTHER Medical Management
Study Locations (20)
California
- UCSD Health La Jolla - La Jolla
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
- Ronald Reagan UCLA Medical Center - Los Angeles
- UCSD Medical Center - Hillcrest Hospital - San Diego
- Stanford University Medical Center - Stanford
Connecticut
- Hartford Hospital - Hartford
- Yale New Haven Hospital - New Haven
Florida
- Jackson Memorial Hospital - Miami
- Tampa General Hospital - Tampa
Massachusetts
- Brigham and Women's Hospital - Boston
- Boston Medical Center - Boston
Minnesota
- M Health Fairview Southdale Hospital - Edina
- M Health Fairview University of Minnesota Medical Center - Minneapolis
Alabama
- University of Alabama Hospital - Birmingham
Georgia
- Grady Memorial Hospital - Atlanta
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2025-01-31 |
| Est. Completion | 2030-01-31 |
| Phase | NA |
What NCT06289985 shows while recruiting
NCT06289985 is an interventional study that assigns participants to a tested intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus, above the 1,439-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (11% higher).
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Endovascular thrombectomy with any FDA-approved category POL or NRY device is the first listed.
NCT06289985 names 20 study sites across 12 states, led by California, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT06289985 about?
NCT06289985 is a clinical study titled "StrokeNet Thrombectomy Endovascular Platform". STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO).
What is the current status of trial NCT06289985?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,600 participants. The study started on 2025-01-31. Estimated completion is 2030-01-31.
What conditions does trial NCT06289985 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT06289985?
The interventions under investigation include: Endovascular thrombectomy with any FDA-approved category POL or NRY device (DEVICE), Medical Management (OTHER).
Who is sponsoring clinical trial NCT06289985?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06289985 being conducted?
This trial has 20 study locations across Alabama, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06289985's enrollment target sits among peer trials
1,600 7th of 66 higher than 60 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
Virtual Reality Based Rehabilitation After Ischemic Stroke
RECRUITING · NA
-
K01 Impacts of Lingual Endurance Exercise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI